These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10221657)

  • 1. Partial block in B lymphocyte development at the transition into the pre-B cell receptor stage in Vpre-B1-deficient mice.
    Mårtensson A; Argon Y; Melchers F; Dul JL; Mårtensson IL
    Int Immunol; 1999 Mar; 11(3):453-60. PubMed ID: 10221657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are co-expressed during B cell development.
    Dul JL; Argon Y; Winkler T; ten Boekel E; Melchers F; Mårtensson IL
    Eur J Immunol; 1996 Apr; 26(4):906-13. PubMed ID: 8625987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of precursor B cell expansion but not allelic exclusion in VpreB1/VpreB2 double-deficient mice.
    Mundt C; Licence S; Shimizu T; Melchers F; Mårtensson IL
    J Exp Med; 2001 Feb; 193(4):435-45. PubMed ID: 11181696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells.
    Mundt C; Licence S; Maxwell G; Melchers F; Mårtensson IL
    Int Immunol; 2006 Jan; 18(1):163-72. PubMed ID: 16361315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VpreB1/VpreB2/lambda 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus.
    Shimizu T; Mundt C; Licence S; Melchers F; Mårtensson IL
    J Immunol; 2002 Jun; 168(12):6286-93. PubMed ID: 12055243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of Vpre-B/lambda 5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice.
    Karasuyama H; Rolink A; Shinkai Y; Young F; Alt FW; Melchers F
    Cell; 1994 Apr; 77(1):133-43. PubMed ID: 8156589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrete early pro-B and pre-B stages in normal human bone marrow as defined by surface pseudo-light chain expression.
    Guelpa-Fonlupt V; Tonnelle C; Blaise D; Fougereau M; Fumoux F
    Eur J Immunol; 1994 Jan; 24(1):257-64. PubMed ID: 8020565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein.
    Corcos D; Dunda O; Butor C; Cesbron JY; Lorès P; Bucchini D; Jami J
    Curr Biol; 1995 Oct; 5(10):1140-8. PubMed ID: 8548286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unique region of surrogate light chain component lambda5 is a heavy chain-specific regulator of precursor B cell receptor signaling.
    Guloglu FB; Bajor E; Smith BP; Roman CA
    J Immunol; 2005 Jul; 175(1):358-66. PubMed ID: 15972669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
    Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
    Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional and surrogate light chains differentially regulate Ig mu and Dmu heavy chain maturation and surface expression.
    Fang T; Smith BP; Roman CA
    J Immunol; 2001 Oct; 167(7):3846-57. PubMed ID: 11564802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transition of pre-BI to pre-BII cells is dependent on the VH structure of the mu/surrogate L chain receptor.
    Ye J; McCray SK; Clarke SH
    EMBO J; 1996 Apr; 15(7):1524-33. PubMed ID: 8612575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precursor B cells showing H chain allelic inclusion display allelic exclusion at the level of pre-B cell receptor surface expression.
    ten Boekel E; Melchers F; Rolink AG
    Immunity; 1998 Feb; 8(2):199-207. PubMed ID: 9492001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Vpre-B3 (8HS-20) molecules by alternative RNA processing.
    Hagiwara S; Tsunetsugu-Yokota Y; Kimoto H; Takemori T
    Int Immunol; 1996 Aug; 8(8):1237-44. PubMed ID: 8918693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
    Shaffer AL; Schlissel MS
    J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal pre-B cells express a receptor complex of mu heavy chains and surrogate light-chain proteins.
    Nishimoto N; Kubagawa H; Ohno T; Gartland GL; Stankovic AK; Cooper MD
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6284-8. PubMed ID: 1906177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
    van Loo PF; Dingjan GM; Maas A; Hendriks RW
    Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VpreB1 enhancer drives developmental stage-specific gene expression in vivo.
    Licence S; Persson C; Mundt C; Mårtensson IL
    Eur J Immunol; 2003 Apr; 33(4):1117-26. PubMed ID: 12672078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells.
    Melchers F; ten Boekel E; Seidl T; Kong XC; Yamagami T; Onishi K; Shimizu T; Rolink AG; Andersson J
    Immunol Rev; 2000 Jun; 175():33-46. PubMed ID: 10933589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.